SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019695
Filing Date
2023-05-09
Accepted
2023-05-09 16:15:52
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-20230331.htm   iXBRL 10-Q 2100365
2 EX-31.1 rcus-ex31_1.htm EX-31 18818
3 EX-31.2 rcus-ex31_2.htm EX-31 18850
4 EX-32.1 rcus-ex32_1.htm EX-32 11121
5 EX-32.2 rcus-ex32_2.htm EX-32 11130
6 GRAPHIC img116675742_0.jpg GRAPHIC 7703
7 GRAPHIC img116675742_1.jpg GRAPHIC 120311
8 GRAPHIC img116675742_2.jpg GRAPHIC 87230
  Complete submission text file 0000950170-23-019695.txt   8008101

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20230331.xsd EX-101.SCH 66291
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20230331_lab.xml EX-101.LAB 424793
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rcus-20230331_cal.xml EX-101.CAL 46832
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20230331_def.xml EX-101.DEF 166250
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20230331_pre.xml EX-101.PRE 300721
63 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20230331_htm.xml XML 1357907
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 23902224
SIC: 2834 Pharmaceutical Preparations